Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
49.90
-2.23 (-4.28%)
At close: May 9, 2025, 4:00 PM
50.00
+0.10 (0.20%)
After-hours: May 9, 2025, 7:43 PM EDT
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
$589,029
Profits / Employee
$82,148
Market Cap
127.51B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNY News
- 21 hours ago - Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label - Reuters
- 1 day ago - Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks. - Barrons
- 4 days ago - Sanofi: Investing in prevention builds Europe's health and competitiveness - GlobeNewsWire
- 10 days ago - Press Release: Annual General Meeting of April 30, 2025 - GlobeNewsWire
- 10 days ago - Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewsWire
- 11 days ago - Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race - GlobeNewsWire
- 16 days ago - Sanofi (SNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug - WSJ